SPI
16.629,11
PKT
+0,26
PKT
±0,00
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.10.10 | Zurich Insurance buy | Banc of America Securities-Merrill Lynch | |
| 25.10.10 | ABB (Asea Brown Boveri) sell | Société Générale Group S.A. (SG) | |
| 25.10.10 | Nestlé buy | Société Générale Group S.A. (SG) | |
| 25.10.10 | Santhera Pharmaceuticals hold | Vontobel Research | |
| 25.10.10 | Nestlé buy | Vontobel Research | |
| 25.10.10 | Novartis buy | Vontobel Research | |
| 22.10.10 | UBS hold | Société Générale Group S.A. (SG) | |
| 22.10.10 | UBS halten | Independent Research GmbH | |
| 25.10.10 | ABB (Asea Brown Boveri) sell | UniCredit Research | |
| 22.10.10 | UBS buy | Vontobel Research | |
| 22.10.10 | Novartis kaufen | Independent Research GmbH | |
| 22.10.10 | Novartis buy | Citigroup Corp. | |
| 22.10.10 | Bucher Industries buy | Vontobel Research | |
| 22.10.10 | ABB (Asea Brown Boveri) hold | Vontobel Research | |
| 22.10.10 | Nestlé buy | Vontobel Research | |
| 22.10.10 | Ypsomed hold | Vontobel Research | |
| 22.10.10 | Clariant buy | Vontobel Research | |
| 22.10.10 | Novartis buy | Vontobel Research | |
| 22.10.10 | Nestlé outperform | Sanford C. Bernstein and Co., Inc. | |
| 22.10.10 | BB Biotech kaufen | Der Aktionär | |
| 25.10.10 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 22.10.10 | Novartis kaufen | National-Bank AG | |
| 21.10.10 | Novartis hold | Jefferies & Company Inc. | |
| 21.10.10 | Novartis buy | SEB AG | |
| 21.10.10 | UBS buy | Vontobel Research | |
| 21.10.10 | Novartis buy | Vontobel Research | |
| 21.10.10 | Temenos buy | Vontobel Research | |
| 21.10.10 | OC Oerlikon hold | Vontobel Research | |
| 21.10.10 | Inficon buy | Vontobel Research | |
| 20.10.10 | Kühne + Nagel International hold | Société Générale Group S.A. (SG) | |
| 20.10.10 | Kühne + Nagel International buy | ING | |
| 19.10.10 | Avolta (ex Dufry) overweight | Morgan Stanley | |
| 19.10.10 | Sulzer buy | Vontobel Research | |
| 19.10.10 | Kühne + Nagel International buy | Vontobel Research | |
| 19.10.10 | Valiant reduce | Vontobel Research | |
| 20.10.10 | UBS hold | UniCredit Research | |
| 20.10.10 | UBS buy | UniCredit Research | |
| 21.10.10 | Novartis buy | Banc of America Securities-Merrill Lynch | |
| 20.10.10 | Roche hold | Citigroup Corp. | |
| 19.10.10 | Meyer Burger Technology neutral | Goldman Sachs Group Inc. |